MBOT Stock Analysis: Buy, Sell, or Hold?
MBOT - Microbot Medical, Inc. Common Stock
$1.79
-0.04 (-1.92%)
▼
5d:
-1.92%
30d:
+4.39%
90d:
-28.6%
BUY
HIGH Confidence
Analysis Updated: Jun 23, 2026 12:00 AM ET
Earnings: Aug 11, 2026
Get Alerted When MBOT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: MBOT shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
✅ BUY SIGNAL: MBOT shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
In-depth Analysis How we analyze
Valuation Analysis: MBOT is currently trading at $1.78, which is considered fair relative to its 30-day fair value range of $1.75 to $1.93. From a valuation perspective, the stock is trading at a discount (Forward PE: -5.7) compared to its historical average (18.5). At these levels, the market is pricing in 0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, MBOT is in a strong uptrend. Immediate support is located at $1.71, while resistance sits at $2.17.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $7.00 (+284.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, MBOT is in a strong uptrend. Immediate support is located at $1.71, while resistance sits at $2.17.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $7.00 (+284.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$1.75 -
$1.93
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
77.1%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 284.6% below Wall St target ($7.00)
- BULLISH: Market expects only 0% annual growth - appears undervalued
Trading Range Analysis
30-Day Trading Range
$1.75 -
$1.93
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$1.71
Resistance Level
$2.18
Current Trend
Strong Uptrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-5.69
Wall Street Target
$7.00
(+284.6%)
PE vs Historical
-5.7 vs 18.5
CHEAP
Share & Embed Analysis
Last updated: June 24, 2026 10:12 AM ET
Data refreshes hourly during market hours. Next update: 11:12 AM
Data refreshes hourly during market hours. Next update: 11:12 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MBOT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ISRG
Intuitive Surgical Inc |
BUY
33 analysts |
$565 | 57 HOLD |
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$88 | 54 HOLD |
|
RMD
ResMed Inc |
BUY
19 analysts |
$262 | 62 BUY |
|
RGEN
Repligen Corporation |
STRONG BUY
19 analysts |
$176 | 50 HOLD |
|
COO
The Cooper Companies, Inc |
BUY
19 analysts |
$81 | 65 BUY |
